Considering the fact that SWAP-70 co-localizes with F-actin only when the cells are stimulated, these results suggest that the actin binding domain of full-length SWAP-70 may be masked and may be exposed only when activated

Considering the fact that SWAP-70 co-localizes with F-actin only when the cells are stimulated, these results suggest that the actin binding domain of full-length SWAP-70 may be masked and may be exposed only when activated. drugs that can inhibit SWAP-70-dependent cell responses were screened. Among various drugs, sanguinarine was found to inhibit transformation of MEFs by SWAP-70-374. This drug was able to inhibit SWAP-70-mediated membrane ruffling as well, suggesting that its effect was closely related to the SWAP-70 signaling pathway. These results suggest that SWAP-70-374 can activate some signaling pathways, including the ERK1/2 pathway, to transform MEFs. == Introduction == SWAP-70 is a phosphatidylinositol trisphosphate (PtdIns(3,4,5)P3) binding protein, that has been implicated to play a role in the formation of cancer. Strong expression of SWAP-70 is often 10Z-Nonadecenoic acid seen in human B-cell neoplasms[1]. SWAP-70 has been also shown to be expressed in higher levels in malignant gliomas than in low-grade ones or normal brain tissue[2]. These results suggest that SWAP-70 may be closely related to formation of malignant tumorsin vivo. Rabbit Polyclonal to TSEN54 Involvement of SWAP-70 in transformation of the cells has also been suggestedin vitro. We have shown that SWAP-70 is required for the anchorage-independent growth of v-Src-transformed MEFs[3]. In addition, growth of the cells lacking SWAP-70 has been shown to be slower than that of the cells expressing SWAP-70[3]. These results suggest that SWAP-70 may be involved in regulation of cell growth in some way. It has been suggested that SWAP-70 is important for cell motility and invasion of the tumor cells[2],[4]. Although how SWAP-70 contributes to the formation of cancers is largely unknown, some of SWAP-70’s activities at the biochemical or cell biological level have been revealed. SWAP-70 contains a pleckstrin homology (PH) domain, which is responsible for PtdIns(3,4,5)P3binding, in the central part and a coiled-coil domain in the carboxyl-terminal half[5],[6]. In addition, carboxyl-terminal region of SWAP-70 has been shown to bind to non-muscle F-actinin vitro[7]. One of the well-studied cell responses related to actin rearrangement is membrane ruffling, which is closely related to cell motility. SWAP-70 translocates from the 10Z-Nonadecenoic acid cytoplasm to the membrane ruffles upon PtdIns 3-kinase activation after growth factor stimulation and co-localizes with F-actin in adherent cells such as MEF or Cos7. Cells lacking SWAP-70 show impaired membrane ruffling after growth factor 10Z-Nonadecenoic acid stimulation, suggesting that SWAP-70 may play a crucial role in induction of membrane ruffling[5]. SWAP-70 lacking the F-actin binding domain has been shown to act as a dominant negative reagent for membrane ruffling, suggesting that this actin-binding activity is important for membrane ruffling[7]. Binding of SWAP-70 to activated Rac1, which has been shown to regulate actin rearrangement including membrane ruffling, has been also detected[7]. Taken together with the fact that SWAP-70 binds to PtdIns(3,4,5)P3, a product 10Z-Nonadecenoic acid of PtdIns 3-kinase, that has been also suggested to be essential for membrane ruffling, it is likely that SWAP-70 is an important molecule that may put the functions of PtdIns(3,4,5)P3, F-actin, and Rac1 together. Supporting these findings, SWAP-70 has been shown to be essential for proper homing of B cells to lymphoid organs, which may require F-actin rearrangement[8]. Because F-actin rearrangement is likely to be related to cell transformation, these findings support the idea that SWAP-70 contributes to tumor formation in some way. Sanguinarine, a benzophenanthridine alkaloid, has been shown to exhibit anti-cancer activityin vivoandin vitro[9],[10],[11],[12],[13],[14],[15]. For instance, sanguinarine exhibits antiproliferative and antiangiogenic effects in melanoma and prevention activity of occurrence of skin cancers. There are also a number of reports suggesting that sanguinarine inhibits growth of tumor cell lines and induces apoptosis. Recently, it has been suggested that sanguinarine interacts with 10Z-Nonadecenoic acid DNA and histones, which might be the mechanism for its anti-tumor activity[16]. However, this does not completely explain the fact that sanguinarine is effective only for certain tumor cell lines. In this paper, we demonstrate that a mutant of SWAP-70 can transform mouse embryo fibroblast and further suggest that an anti-cancer drug, sanguinarine inhibits SWAP-70-dependent cell responses. == Materials and Methods == == Cells and culture conditions == Mouse embryo fibroblasts (MEFs) were cultured from a 129/SvEMS.